Last reviewed · How we verify
Bupropion-Naltrexone
Bupropion-Naltrexone is a Small molecule drug developed by WW International Inc. It is currently FDA-approved.
At a glance
| Generic name | Bupropion-Naltrexone |
|---|---|
| Sponsor | WW International Inc |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1) (PHASE2, PHASE3)
- Preoperative Weight Loss for Open Abdominal Wall Reconstruction (NA)
- A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients (PHASE1, PHASE2)
- Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients (PHASE1)
- Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder (PHASE4)
- Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder (PHASE3)
- Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a) (PHASE2, PHASE3)
- A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bupropion-Naltrexone CI brief — competitive landscape report
- Bupropion-Naltrexone updates RSS · CI watch RSS
- WW International Inc portfolio CI
Frequently asked questions about Bupropion-Naltrexone
What is Bupropion-Naltrexone?
Bupropion-Naltrexone is a Small molecule drug developed by WW International Inc.
Who makes Bupropion-Naltrexone?
Bupropion-Naltrexone is developed and marketed by WW International Inc (see full WW International Inc pipeline at /company/ww-international-inc).
What development phase is Bupropion-Naltrexone in?
Bupropion-Naltrexone is FDA-approved (marketed).
Related
- Manufacturer: WW International Inc — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing